The outlook of companies tied to Sildenafil's history presents a intricate investment landscape. While the initial surge generated substantial profits , generic competition have significantly impacted sales . Investing in connected pharmaceutical businesses now requires a discerning assessment of proprietary rights , evolving patient trends , and t